Kenneth R. Fisher's most recent trade in Provident Bancorp Inc was a trade of 12,000 Common Stock done . Disclosure was reported to the exchange on Aug. 20, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Provident Bancorp Inc | Kenneth R. Fisher | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 12,000 | 17,000 (0%) | 0% | 0 | Common Stock | |
Provident Bancorp Inc | Kenneth R. Fisher | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 8,000 | 25,000 (0%) | 0% | 0 | Common Stock | |
Provident Bancorp Inc | Kenneth R. Fisher | EVP and CFO | Purchase of securities on an exchange or from another person at price $ 9.59 per share. | 14 Jun 2024 | 2,500 | 2,500 (0%) | 0% | 9.6 | 23,963 | Common Stock |
Provident Bancorp Inc | Kenneth R. Fisher | EVP and CFO | Purchase of securities on an exchange or from another person at price $ 9.63 per share. | 14 Jun 2024 | 2,500 | 5,000 (0%) | 0% | 9.6 | 24,066 | Common Stock |
Bluejay Diagnostics Inc | Kenneth R. Fisher | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.44 per share. | 01 Feb 2023 | 112,500 | 152,500 | - | 0.4 | 49,500 | Common Stock |
Bluejay Diagnostics Inc | Kenneth R. Fisher | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. | 01 Feb 2023 | 39,316 | 113,184 | - | 0.4 | 17,299 | Common Stock |
Bluejay Diagnostics Inc | Kenneth R. Fisher | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 26 Aug 2022 | 20,000 | 40,000 | - | 1.0 | 20,600 | Common Stock |
NextTrip Inc. | Ronald Kenneth Fisher | VP of Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 1,751 | 1,751 | - | - | Stock Option (right to buy) | |
NextTrip Inc. | Ronald Kenneth Fisher | VP of Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 87,335 | 87,335 | - | - | Stock Appreciation Right | |
NextTrip Inc. | Ronald Kenneth Fisher | VP of Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 5,736 | 5,736 | - | - | Stock Option (right to buy) | |
Bluejay Diagnostics Inc | Kenneth R. Fisher | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 25 Apr 2022 | 20,000 | 20,000 | - | 1.0 | 19,800 | Common Stock |
Bluejay Diagnostics Inc | Kenneth R. Fisher | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 65,000 | 65,000 | - | - | Option (right to buy) | |
NextTrip Inc. | Ronald Kenneth Fisher | VP of Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2021 | 30,313 | 30,313 | - | - | Stock Appreciation Right | |
NextTrip Inc. | Ronald Kenneth Fisher | VP of Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2021 | 30,313 | 30,313 | - | - | Stock Option (right to buy) | |
NextTrip Inc. | Ronald Kenneth Fisher | VP of Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2020 | 12,019 | 12,019 | - | - | Stock Appreciation Right | |
NextTrip Inc. | Ronald Kenneth Fisher | VP of Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2020 | 23,331 | 23,331 | - | - | Stock Option (right to buy) |